Compare Honeywell International Inc (HON) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Honeywell International Inc trades at $207 (market cap $65.96B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.52 (market cap $5.85B). The key difference: Honeywell International Inc is far larger — about 11.3× Iovance Biotherapeutics Inc. Common Stock's market cap, and Honeywell International Inc pays a 1.35% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 90 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| HON | IOVA | |
|---|---|---|
Market Cap | $65.96B | $5.85B |
Volume | 2,009,898 | 14,517,176 |
Sector | Industrials | Health |
52-Week High | $248.79 | $14.82 |
52-Week Low | $188.14 | $1.81 |
Typical Hold Time | 90 Days | 0 Days |
Enterprise Value | $90.75B | $5.78B |
Dividend Yield | 1.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 2.95% on the day, with a bearish technical signal despite strong fundamentals including a low P/E of 8 and robust profitability margins. Recent quarterly earnings have consistently beaten expectations, and the company secured a significant $300 million refinery project with Dangote. Analyst consensus remains strongly bullish with a $259.25 price target, representing 25% upside potential from current levels.
The stock presents a compelling value opportunity given its discounted valuation metrics and consistent earnings outperformance, though investors face near-term technical headwinds and execution risks from the company's recent strategic transformation into a pure-play automation business following the spin-off of its aerospace and advanced materials divisions.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
